Founded in 1941, a well-known feed additive brand, a subsidiary of Novozymes Group of Denmark, is the world's largest manufacturer of industrial enzyme preparations and industrial microbial preparations
Novozymes is a world leader in bio-innovation. The company works with customers across a wide range of industries to develop future-oriented industrial biologic solutions that advance their businesses and improve the way the planet's resources are used.
Novozymes has more than 700 products in 130 countries around the world. The company's bio-innovations provide superior sustainable solutions for the needs of a rapidly changing future market, improving industrial efficiency and protecting the planet's resources. From removing trans fatty acids from food to powering the advanced biofuels of the future, Novozymes' natural solutions are used in a wide range of industries. More than 6,500 patents are a testament to Novozymes' never-ending spirit of exploration and unleashing the charm of science and technology contained in nature. Novozymes employs more than 6,000 people worldwide in R&D, production, sales and administration. Novozymes is listed on the Copenhagen Stock Exchange in Denmark (ticker code NZYM B).
Core business
Industrial enzymes and microbial preparations. Novozymes develops new business areas through internal projects, strategic alliances, and commercial acquisitions.
Novozymes ChinaIt is a wholly-owned subsidiary of Novozymes Group in China and is one of the largest Danish companies in China. China plays an important role in Novozymes' globalization strategy and has gradually become the Group's most important business growth engine and R&D, production and operation center. Up to now, Novozymes has more than 1,000 employees in R&D, production, sales, marketing and other functional departments in six cities in China. Novozymes provides innovative and sustainable solutions to customers in the home care, textile, wastewater treatment, food and beverage, agriculture and bioenergy sectors in China.
In China, Novozymes adheres to the "triple bottom line" of business performance, environmental performance and social responsibility, and actively develops new products and applications suitable for the local market to solve the problems faced by China's industry and process. In 2015, Novozymes put forward the strategy of "cooperation to build impact", and is committed to taking root in China's development and becoming a trusted and important partner in China's sustainable development process through continuous in-depth cooperation with the Chinese government, scientific research institutions, universities and Chinese enterprises.
Novozymes invests 13%-14% of its annual turnover in R&D every year. Novozymes China R&D Center was completed in 1995 and officially moved to Novozymes China Headquarters in Zhongguancun Science Park, Haidian District, Beijing in 1997. The R&D center is equipped with world-class biotechnology laboratory equipment, where many scientists, scholars and researchers from home and abroad carry out cutting-edge research in various core fields. As an important part of the global R&D strategy, Novozymes' China R&D Center covers many of Novozymes' core businesses and is seamlessly integrated into the global R&D system.
